Literature DB >> 28688684

Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.

Dina V Hingorani1, Aaron J Lemieux1, Joseph R Acevedo1, Heather L Glasgow2, Suraj Kedarisetty1, Michael A Whitney3, Alfredo A Molinolo4, Roger Y Tsien5, Quyen T Nguyen6.   

Abstract

OBJECTIVES: Ratiometric cell-penetrating-peptides (RACPP) are hairpin-shaped molecules that undergo cleavage by tumor-associated proteases resulting in measurable Cy5:Cy7 fluorescence ratiometric change to label cancer in vivo. We evaluated an MMP cleavable RACPP for use in the early detection of malignant lesions in a carcinogen-induced rodent tumor model.
METHODS: Wild-type immune-competent mice were given 4-nitroquinoline-oxide (4NQO) for 16weeks. Oral cavities from live mice that had been intravenously administered MMP cleavable PLGC(Me)AG-RACPP were serially imaged from week 11 through week 21 using white-light reflectance and Cy5:Cy7 ratiometric fluorescence.
RESULTS: In an initial study we found that at week 21 nearly all mice (13/14) had oral cavity lesions, of which 90% were high-grade dysplasia or invasive carcinoma. These high-grade lesions were identifiable with white light reflectance and RACPP Cy5:Cy7 ratiometric fluorescence with similar detectability, Area Under Curve (AUC) for RACPP detection was 0.97 (95% Confidence interval (CI)=0.92-1.02, p<0.001), sensitivity=89%, specificity=100%. In a follow up study, oral cavity lesions generated by 4NQO were imaged and histologically analyzed at weeks 16, 18 and 21. In this study we showed that RACPP-fluorescence detection positively identified 15 squamous cell carcinomas (in 6 separate mice) that were poorly visible or undetectable by white light reflectance.
CONCLUSIONS: RACPP ratiometric fluorescence can be used to accurately detect carcinogen-induced carcinoma in immunocompetent mice that are poorly visible or undetectable by white light reflectance.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Carcinogen-induced head and neck squamous cell carcinoma; Enzyme responsive; In vivo; Matrix metalloproteinase; Ratiometricfluorescence imaging

Mesh:

Substances:

Year:  2017        PMID: 28688684      PMCID: PMC5575898          DOI: 10.1016/j.oraloncology.2017.06.009

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  34 in total

1.  Tumor and salivary matrix metalloproteinase levels are strong diagnostic markers of oral squamous cell carcinoma.

Authors:  Marni Stott-Miller; John R Houck; Pawadee Lohavanichbutr; Eduardo Méndez; Melissa P Upton; Neal D Futran; Stephen M Schwartz; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

Review 2.  White lesions in the oral cavity: clinical presentation, diagnosis, and treatment.

Authors:  Kyle Burke Jones; Richard Jordan
Journal:  Semin Cutan Med Surg       Date:  2015-12

3.  Value of narrow band imaging in the early diagnosis of laryngeal cancer.

Authors:  Marcel Kraft; Karolos Fostiropoulos; Nicolas Gürtler; André Arnoux; Nikolaos Davaris; Christoph Arens
Journal:  Head Neck       Date:  2015-01-27       Impact factor: 3.147

Review 4.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

Authors:  Maura L Gillison
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

Review 5.  [Molecular imaging of head and neck cancers : Perspectives of PET/MRI].

Authors:  P Stumpp; S Purz; O Sabri; T Kahn
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

6.  MMP-2 expression in 102 patients with glottic laryngeal cancer.

Authors:  Antony Mallis; Afshin Teymoortash; Nicholas S Mastronikolis; Jochen A Werner; Theodoros A Papadas
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-06-11       Impact factor: 2.503

7.  Immunoexpression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in the metastasis of squamous cell carcinoma of the human tongue.

Authors:  C X Zhou; Y Gao; N W Johnson; J Gao
Journal:  Aust Dent J       Date:  2010-12       Impact factor: 2.291

8.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides.

Authors:  Tao Jiang; Emilia S Olson; Quyen T Nguyen; Melinda Roy; Patricia A Jennings; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

Review 9.  Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.

Authors:  Shanthi Marur; Arlene A Forastiere
Journal:  Mayo Clin Proc       Date:  2016-03       Impact factor: 7.616

10.  Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.

Authors:  Elamprakash N Savariar; Csilla N Felsen; Nadia Nashi; Tao Jiang; Lesley G Ellies; Paul Steinbach; Roger Y Tsien; Quyen T Nguyen
Journal:  Cancer Res       Date:  2012-11-27       Impact factor: 12.701

View more
  2 in total

1.  Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.

Authors:  Lise Boon; Estefania Ugarte-Berzal; Erik Martens; Jennifer Vandooren; Vasily Rybakin; Didier Colau; Monica Gordon-Alonso; Pierre van der Bruggen; Walter Stöcker; Christoph Becker-Pauly; Peter Witters; Eva Morava; Jaak Jaeken; Paul Proost; Ghislain Opdenakker
Journal:  FEBS J       Date:  2018-11-30       Impact factor: 5.542

2.  Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs.

Authors:  Dina V Hingorani; Maria F Camargo; Maryam A Quraishi; Stephen R Adams; Sunil J Advani
Journal:  Pharmaceutics       Date:  2021-03-10       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.